<--- Back to Details
First PageDocument Content
Macrolides / Type 1 hypersensitivity / Autoimmune diseases / Tacrolimus / Atopic dermatitis / Pimecrolimus / Eczema / Atopy / Topical steroid / Medicine / Lymphoma / Immunosuppressants
Date: 2005-02-11 16:14:06
Macrolides
Type 1 hypersensitivity
Autoimmune diseases
Tacrolimus
Atopic dermatitis
Pimecrolimus
Eczema
Atopy
Topical steroid
Medicine
Lymphoma
Immunosuppressants

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 187,50 KB

Share Document on Facebook

Similar Documents

MEDA Pharmaceuticals Pty Ltd Elidel® Cream Pimecrolimus 1 % w/w Consumer Medicine Information

DocID: 1mrCV - View Document

New Zealand Datasheet Name of Medicine ELIDEL® Pimecrolimus 1% Cream Presentation

DocID: 1mrsD - View Document

Atopic dermatitis / Eczema / Immunosuppressants / Atopy / Pimecrolimus / SCORAD / Dermatitis / Anatomy / Probiotic / Type 1 hypersensitivity / Health / Medicine

PDF Document

DocID: 17f7c - View Document

Medicine / Health / Pimecrolimus / Tacrolimus / Ascomycin / Atopic dermatitis / Light therapy / Mark G. Lebwohl / Generalized pustular psoriasis / Immunosuppressants / Psoriasis / Macrolides

Journal of IMAB - Annual Proceeding (Scientific Papers) 2008, book 1 TREATMENT OF PSORIASIS VULGARIS WITH ELIDEL S. Racheva, R. Bachvarova, J. Dimitrova Department and clinic of dermatovenerology

DocID: 12xu8 - View Document

Corticosteroids / Chemistry / Tacrolimus / Pimecrolimus / Health / Autoimmune diseases / Medicine / Atopic dermatitis / Atopy / Immunosuppressants / Macrolides / Type 1 hypersensitivity

TOPICAL IMMUNOMODULATOR CRITERIA Pharmacology: Pimecrolimus inhibits the calcium-dependent phosphatase (calcineurin), interfering with T-cell activation and transcription of early cytokines. Thus, it decreases the synthe

DocID: MiMH - View Document